We utilized immunohistochemistry to demonstrate increased CHOP-positive cells in OI osteoblasts with a trend toward a further differentiated increase in osteoblasts from patients with a severe vs. moderate phenotype. The gene discussed is DDIT3; the disease is osteogenesis imperfecta.